PERCEPTIVE ADVISORS LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-16 9:02 pm Unchanged | 2024-12-12 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 12,757,562 19.500% | 0 (Unchanged) | Filing |
| 2024-08-15 6:31 pm Sale | 2024-08-14 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 12,757,562 19.500% | -1 (-0.00%) | Filing |
| 2024-02-14 4:29 pm Unchanged | 2024-02-14 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 12,757,563 24.300% | 0 (Unchanged) | Filing |
| 2023-06-02 4:16 pm Purchase | 2023-05-31 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 12,757,563 25.800% | 3,610,832 (+39.48%) | Filing |
| 2022-04-14 5:10 pm Purchase | 2022-04-07 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 9,146,731 24.800% | 5,924,170 (+183.83%) | Filing |
| 2020-06-01 5:25 pm Purchase | 2020-05-05 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 3,222,561 24.900% | 3,222,561 (New Position) | Filing |